Project Information

Bid Title

6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits

Issuing Agency

VETERANS AFFAIRS, DEPARTMENT OF

Location

N/A

Published Date

Oct 2, 2026

Closing Date

Oct 16, 2026

Government Level

Federal

Status

Closed

Ref. #

36C24227Q0036

Original Source

Join to Access Full Details

Bid Inquiries

Join to Access Full Details

Bid Documents

Join to Access Full Details

Project Description

Follow

6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits

Active

Contract Opportunity

Notice ID

36C24227Q0036

Related Notice

Department/Ind. Agency

VETERANS AFFAIRS, DEPARTMENT OF

Sub-tier

VETERANS AFFAIRS, DEPARTMENT OF

Office

242-NETWORK CONTRACT OFFICE 02 (36C242)

General Information

• Contract Opportunity Type: Special Notice (Original)
• Original Published Date: Oct 02, 2026 04:01 pm EDT
• Original Response Date: Oct 16, 2026 04:00 pm EDT
• Inactive Policy: Manual
• Original Inactive Date: Oct 31, 2026
• Initiative:
  • None

Classification

• Original Set Aside:
• Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
• NAICS Code:
  • 334516 - Analytical Laboratory Instrument Manufacturing
• Place of Performance:

Description

This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions.

The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC).

This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements.

This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a:

Capability Statement (1 page maximum)
Company Name
UEI Number
Socioeconomic Status
Proof of authorization to provide the OEM reagents

Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov
A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future.

Prospective contractors must be registered in SAM.gov to be eligible for award.

Attachments/Links

Contact Information

Contracting Office Address

• 113 HOLLAND AVE
• ALBANY , NY 12208
• USA

Primary Point of Contact

• Myra F. Green
• Myra.Green2@va.gov

Secondary Point of Contact

History

• Oct 02, 2026 04:01 pm EDTSpecial Notice (Original)

Commodity Codes

• FSC 65Medical, Dental, and Veterinary Equipment and Supplies

• NAICS 334516Analytical Laboratory Instrument Manufacturing

* Disclaimer: Government BidHub provides information on bids, RFPs (Requests for Proposals), and RFQs (Requests for Qualifications) solely for convenience and informational purposes. This site is not an official public notice board. For official details, responses, or inquiries, please contact the relevant government agency directly.